Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;13(1):112.
doi: 10.1186/cc7155. Epub 2009 Jan 23.

Recombinant human activated protein C in acute lung injury: what is the role of bronchial circulation?

Marc O Maybauer  1 , Daniel L Traber, Dirk M Maybauer
Affiliations
Review

Recombinant human activated protein C in acute lung injury: what is the role of bronchial circulation?

Marc O Maybauer et al. Crit Care. 2009.

Abstract

Impairment of the protein C pathway plays a central role in the pathogenesis of sepsis. Treatment with recombinant human activated protein C (rhAPC) has been reported to increase survival from severe sepsis. Protein C levels also decrease markedly in acute lung injury, of both septic and nonseptic origin. Low levels of protein C in acute lung injury are associated with poor clinical outcome. The present article discusses the beneficial effects of rhAPC in oleic acid-induced lung injury as well as the controversies between different animal models and the timing of drug administration. The unique bronchial circulation in ovine models seems to be responsible for the beneficial effects of rhAPC when given simultaneously to the injury.

PubMed Disclaimer

Comment on

References

    1. Waerhaug K, Kirov MY, Kuzkov VV, Kuklin VN, Bjertnaes LJ. Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep. Crit Care. 2008;12:R146. doi: 10.1186/cc7128. - DOI - PMC - PubMed
    1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709. doi: 10.1056/NEJM200103083441001. - DOI - PubMed
    1. Levi M, Poll T van der. Recombinant human activated protein C: current insights into its mechanism of action. Crit Care. 2007;11(Suppl 5):S3. doi: 10.1186/cc6154. - DOI - PMC - PubMed
    1. Shorr AF, Bernard GR, Dhainaut JF, Russell JR, Macias WL, Nelson DR, Sundin DP. Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome. Crit Care. 2006;10:R92. doi: 10.1186/cc4946. - DOI - PMC - PubMed
    1. Matthay MA, Ware LB. Plasma protein C levels in patients with acute lung injury: prognostic significance. Crit Care Med. 2004;32(5 Suppl):S229–S232. doi: 10.1097/01.CCM.0000126121.56990.D3. - DOI - PubMed

MeSH terms

LinkOut - more resources